HUMAN ADJUVANT DISEASE SECONDARY TO FOREIGN SUBSTANCE INJECTIONS AS A CAUSE OF SECONDARY LOWER EXTREMITY LYMPHEDEMA.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 195
- By:
- Publication type:
- Article
Works matching IS 00247766 AND DT 2021 AND VI 54 AND IP 4
Results: 6
1
2
PREVALENCE OF CLINICAL MANIFESTATIONS AND ORTHOPEDIC ALTERATIONS IN PATIENTS WITH LIPEDEMA: A PROSPECTIVE COHORT STUDY.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 170
- By:
- Publication type:
- Article
3
ISL NEWS.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 214
- Publication type:
- Article
4
OUTCOMES OF NEONATAL CHYLOUS EFFUSIONS: A 20-YEAR WEST-AUSTRALIAN TERTIARY CENTER EXPERIENCE.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 204
- By:
- Publication type:
- Article
5
EXPANDING THE SPECTRUM OF GORHAM STOUT DISEASE EXPLORING A SINGLE CENTER PEDIATRIC CASE SERIES.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 182
- By:
- Publication type:
- Article
6
HUMAN CHROMOSOME MAP OF LYMPHEDEMA-LYMPHANGIOGENESIS GENES: TEMPLATE FOR CURRENT AND FUTURE DISCOVERY.
- Published in:
- Lymphology, 2021, v. 54, n. 4, p. 167
- By:
- Publication type:
- Article